US judge denies Sanofi-Aventis's bid to stop generic rival for Lovenox

A federal judge has denied Sanofi-Aventis 's request fora preliminary injunction that would have directed the US FDA to suspend and withdraw its approval of a generic version of Lovenox (enoxaparin sodium) from Sandoz (Novartis) and partner Momenta Pharmaceuticals, which has been on the market for several weeks. As a result of the ruling, sales of generic Lovenox will proceed.

A federal judge has denied Sanofi-Aventis 's request fora preliminary injunction that would have directed the US FDA to suspend and withdraw its approval of a generic version of Lovenox (enoxaparin sodium) from Sandoz (Novartis) and partner Momenta Pharmaceuticals, which has been on the market for several weeks. As a result of the ruling, sales of generic Lovenox will proceed.

In a 33-page opinion, Judge Emmet Sullivan of the US District Court for the District of Columbia said that the court found no reason to doubt the FDA's rationale...

More from Business

More from Scrip